All Stories

  1. Feasibility and potential effects of a combined money advice and psychological therapy intervention within National Health Service Talking Therapies services
  2. Cognitive Remediation Is an Evidence-Based Psychological Therapy: Isn’t It Time It Was Treated Like One?
  3. Exploring the dynamic relationships between nocturnal heart rate, sleep disruptions, anxiety levels, and depression severity over time in recurrent major depressive disorder
  4. Assessing seasonal and weather effects on depression and physical activity using mobile health data
  5. Representation of women in scientific subjects: overview of systematic reviews investigating career progress in academic publishing with a focus on mental health – ERRATUM
  6. Representation of women in scientific subjects: overview of systematic reviews investigating career progress in academic publishing with a focus on mental health
  7. Exploring the involvement of people with lived experience of mental disorders in co-developing outcome measures: a systematic review
  8. A network approach exploring the effects of cognitive remediation on cognition, symptoms, and functioning in early psychosis
  9. Data Visualization Preferences in Remote Measurement Technology for Individuals Living With Depression, Epilepsy, and Multiple Sclerosis: Qualitative Study
  10. The relationship between wearable-derived sleep features and relapse in Major Depressive Disorder
  11. “Food for Thought”: Improving Cognition in People With Schizophrenia
  12. Longitudinal Assessment of Seasonal Impacts and Depression Associations on Circadian Rhythm Using Multimodal Wearable Sensing: Retrospective Analysis
  13. Social influences on the relationship between dissociation and psychotic-like experiences
  14. Identifying depression-related topics in smartphone-collected free-response speech recordings using an automatic speech recognition system and a deep learning topic model
  15. Thinking About the Future of Cognitive Remediation Therapy Revisited: What Is Left to Solve Before Patients Have Access?
  16. Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trial
  17. Evaluating remote delivery of cognitive remediation in people with psychosis
  18. Longitudinal Modeling of Depression Shifts Using Speech and Language
  19. Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
  20. Why did we reject your paper?
  21. Understanding the Mechanisms of Cognitive Remediation on Recovery in People With Early Psychosis: A Mediation and Moderation Analysis
  22. Experiencing hallucinations in daily life: The role of metacognition
  23. Evaluating the acceptability of remote cognitive remediation from the perspective of psychosis service users
  24. The association between area-level factors and mortality in severe mental illnesses: A systematic review
  25. Metacognition and psychosis-spectrum experiences: A study of objective and subjective measures
  26. Evaluation of a new online cognitive remediation therapy ( CIRCuiTS TM ) training for mental health professionals
  27. Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual
  28. Multilingual markers of depression in remotely collected speech samples: A preliminary analysis
  29. Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scale
  30. The anxiety of the lone editor: fraud, paper mills and the protection of the scientific record
  31. A case series study of compassion‐focused therapy for distressing experiences in psychosis
  32. Classifying depression symptom severity: Assessment of speech representations in personalized and generalized machine learning models.
  33. Challenges in Using mHealth Data From Smartphones and Wearable Devices to Predict Depression Symptom Severity: Retrospective Analysis
  34. What is evidence? bridging the gap between trials and treatment implementation
  35. Barriers to and Facilitators of Using Remote Measurement Technology in the Long-Term Monitoring of Individuals With ADHD: Interview Study
  36. Patient preferences for key drivers and facilitators of adoption of mHealth technology to manage depression: A discrete choice experiment
  37. Use of cognitive remediation to treat negative symptoms in schizophrenia: is it time yet?
  38. The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severity
  39. Measures of Social and Occupational Function in Early Psychosis: A Systematic Review and Meta-analysis
  40. Participant perspectives on cognitive remediation and social recovery in early psychosis (CReSt‐R): An acceptability study
  41. Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants
  42. Moderators of metacognitive strategy training for executive functioning in early schizophrenia and psychosis risk
  43. Long-term participant retention and engagement patterns in an app and wearable-based multinational remote digital depression study
  44. Understanding the Subjective Experience of Long-term Remote Measurement Technology Use for Symptom Tracking in People With Depression: Multisite Longitudinal Qualitative Analysis
  45. Detecting anomalous experiences in the community: The Transpersonal Experiences Questionnaire ( TEQ )
  46. The impact of patient involvement on participant opinions of information sheets
  47. Evaluating the mechanisms of social cognition intervention in schizophrenia: A proof-of-concept trial
  48. Experiences of health tracking in mobile apps for multiple sclerosis: A qualitative content analysis of user reviews
  49. The association between persistent cognitive difficulties and depression and functional outcomes in people with major depressive disorder
  50. Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis
  51. Health Tracking via Mobile Apps for Depression Self-management: Qualitative Content Analysis of User Reviews
  52. Cognitive trajectories following onset of psychosis: a meta-analysis – CORRIGENDUM
  53. Barriers to and Facilitators of Using Remote Measurement Technology in the Long-Term Monitoring of Individuals With ADHD: Interview Study (Preprint)
  54. Modern media and mental health: help or hindrance?
  55. Evaluating how treatment adherence influences cognitive remediation outcomes
  56. Factors Influencing Increased Use of Technology to Communicate With Others During the COVID-19 Pandemic: Cross-sectional Web-Based Survey Study
  57. Associations Between Depression Symptom Severity and Daily-Life Gait Characteristics Derived From Long-Term Acceleration Signals in Real-World Settings: Retrospective Analysis
  58. Experience of Inpatient Mental Health Care Assessed With Service User–Developed and Conventional Patient-Reported Outcome Measures
  59. Cognitive trajectories following onset of psychosis: a meta-analysis
  60. Comparing Professional and Consumer Ratings of Mental Health Apps: Mixed Methods Study
  61. Cost-Effectiveness of Positive Memory Training (PoMeT) for the Treatment of Depression in Schizophrenia
  62. Lessons learned from recruiting into a longitudinal remote measurement study in major depressive disorder
  63. Cognitive remediation for people with bipolar disorder: The contribution of session attendance and therapy components to cognitive and functional outcomes
  64. Investigating mental health service user views of stigma on Twitter during COVID-19: a mixed-methods study
  65. The Engagement Challenge: Feasibility and Acceptability of Cognitive Remediation for Teenagers in the Care of Youth Protection Services
  66. Investigating a psychological model of mental conditions and coping during the COVID-19 pandemic driven by participatory methods
  67. Health tracking via mobile apps for depression self-management: a qualitative content analysis of user reviews (Preprint)
  68. Cognitive Remediation and Social Recovery in Early Psychosis (CReSt-R): protocol for a pilot randomised controlled study
  69. Key Drivers and Facilitators of the Choice to Use mHealth Technology in People With Neurological Conditions: Observational Study
  70. Key questions: research priorities for student mental health
  71. Data Visualization for Chronic Neurological and Mental Health Condition Self-management: Systematic Review of User Perspectives
  72. The organisational climate of NHS Early Intervention Services (EIS) for psychosis: a qualitative analysis
  73. Towards personalizing cognitive remediation therapy: Examining moderators of response for euthymic people with bipolar disorder
  74. Longitudinal Relationships Between Depressive Symptom Severity and Phone-Measured Mobility: Dynamic Structural Equation Modeling Study
  75. Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
  76. Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study
  77. Identifying schizophrenia stigma on Twitter: a proof of principle model using service user supervised machine learning
  78. Trauma and Social Pathways to Psychosis, and Where the Two Paths Meet
  79. European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
  80. Computerized or manual? Long term effects of cognitive remediation on schizophrenia
  81. Across the continuum: Associations between (fluctuations in) momentary self-esteem and psychotic experiences
  82. Research and mental health during COVID-19—advice and some requests
  83. How to make study documents clear and relevant: the impact of patient involvement
  84. Cognitive impairment in euthymic patients with bipolar disorder: Prevalence estimation and model selection for predictors of cognitive performance
  85. Predictors of psychosocial functioning in euthymic patients with bipolar disorder: A model selection approach
  86. Investigating the impact of COVID-19 lockdown on adults with a recent history of recurrent major depressive disorder: a multi-Centre study using remote measurement technology
  87. Investigating Mental Health Service User Opinions on Clinical Data Sharing: Qualitative Focus Group Study
  88. Terms and conditions apply: Critical issues for readability and jargon in mental health depression apps
  89. Remote Smartphone-Based Speech Collection: Acceptance and Barriers in Individuals with Major Depressive Disorder
  90. Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia
  91. Predicting Depressive Symptom Severity Through Individuals’ Nearby Bluetooth Device Count Data Collected by Mobile Phones: Preliminary Longitudinal Study
  92. Does cognitive improvement translate into functional changes? Exploring the transfer mechanisms of cognitive remediation therapy for euthymic people with bipolar disorder
  93. Investigating Mental Health Service User Opinions on Clinical Data Sharing: Qualitative Focus Group Study (Preprint)
  94. Shared goals for mental health research: what, why and when for the 2020s
  95. Relationship Between Major Depression Symptom Severity and Sleep Collected Using a Wristband Wearable Device: Multicenter Longitudinal Observational Study
  96. Proposed reforms of the Mental Health Act
  97. Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia
  98. A process for reviewing mental health apps: Using the One Mind PsyberGuide Credibility Rating System
  99. Ketamine treatment for depression: qualitative study exploring patient views
  100. Development and Validation of a Nonremission Risk Prediction Model in 
First-Episode Psychosis: An Analysis of 2 Longitudinal Studies
  101. Investigating Patient Acceptability of Stratified Medicine for Schizophrenia: A Mixed Methods Study
  102. Patient Preferences for Antipsychotic Drug Side Effects: A Discrete Choice Experiment
  103. Can IQ moderate the response to cognitive remediation in people with schizophrenia?
  104. Remote Assessment of Disease and Relapse in Epilepsy: Protocol for a Multicenter Prospective Cohort Study
  105. Positive memory training for the treatment of depression in schizophrenia: A randomised controlled trial
  106. Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth
  107. Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study
  108. Role of cognitive reserve in cognitive variability in euthymic individuals with bipolar disorder: cross-sectional cluster analysis
  109. Data Visualization for Chronic Neurological and Mental Health Condition Self-management: Systematic Review of User Perspectives (Preprint)
  110. Terms and Conditions apply: Critical issues for readability and jargon in mental health apps (Preprint)
  111. Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19
  112. How mental health care should change as a consequence of the COVID-19 pandemic
  113. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial
  114. Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study (Preprint)
  115. Research priorities for the COVID‐19 pandemic and beyond: A call to action for psychological science
  116. Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study
  117. The contribution of dynamic risk factors in predicting aggression: A systematic review including inpatient forensic and non-forensic mental health services
  118. Patients’ Measurement Priorities for Remote Measurement Technologies to Aid Chronic Health Conditions: Qualitative Analysis
  119. Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
  120. Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study
  121. A role for lived experience mental health leadership in the age of Covid-19
  122. The acceptability of real‐time health monitoring among community participants with depression: A systematic review and meta‐analysis of the literature
  123. Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
  124. Gender diversity in the Journal of Mental Health – how are we doing and what do we need to do?
  125. A systematic review of moderators of cognitive remediation response for people with schizophrenia
  126. Investigating subjective cognitive complaints in psychosis: Introducing the brief scale to Investigate cognition in schizophrenia (SSTICS-Brief)
  127. Do we really need a “new” cognitive therapy for bipolar disorder? Paradigm refinements and treatment mechanisms for cognitive remediation
  128. Patients' experience of wearing multimodal sensor devices intended to detect epileptic seizures: A qualitative analysis
  129. Cognitive remediation for schizophrenia: An expert working group white paper on core techniques
  130. The impact of ward climate on staff perceptions of barriers to research‐driven service changes on mental health wards: A cross‐sectional study
  131. Technology-based interventions for mental health support after stroke: A systematic review of their acceptability and feasibility
  132. The side effects of service changes: exploring the longitudinal impact of participation in a randomised controlled trial (DOORWAYS) on staff perceptions of barriers to change
  133. Can we trust observational data? Keeping bias in mind
  134. Recovery from daily-life stressors in early and chronic psychosis
  135. Cognitive enhancement interventions for people with bipolar disorder: A systematic review of methodological quality, treatment approaches, and outcomes
  136. Predicting Inpatient Aggression in Forensic Services Using Remote Monitoring Technology: Qualitative Study of Staff Perspectives
  137. Emotional outcomes in clinically isolated syndrome and early phase multiple sclerosis: a systematic review and meta-analysis
  138. Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: A qualitative analysis
  139. Predicting Inpatient Aggression in Forensic Services Using Remote Monitoring Technology: Qualitative Study of Staff Perspectives (Preprint)
  140. Who will benefit from computerized cognitive remediation therapy? Evidence from a multisite randomized controlled study in schizophrenia
  141. Towards the Design of Ethical Standards Related to Digital Mental Health and all Its Applications
  142. Engaging across dimensions of diversity: A cross-national perspective on mHealth tools for managing relapsing remitting and progressive multiple sclerosis
  143. Why Reviewing Apps Is Not Enough: Transparency for Trust (T4T) Principles of Responsible Health App Marketplaces
  144. Exploring the effects of cognitive remediation on metacognition in people with schizophrenia
  145. Blending active and passive digital technology methods to improve symptom monitoring in early psychosis
  146. Barriers to and Facilitators of Engagement With mHealth Technology for Remote Measurement and Management of Depression: Qualitative Analysis
  147. Digital Exclusion Among Mental Health Service Users: Qualitative Investigation
  148. Racing towards a digital paradise or a digital hell?
  149. Changing nurses’ views of the therapeutic environment: randomised controlled trial
  150. The nuts and bolts of Cognitive Remediation: Exploring how different training components relate to cognitive and functional gains
  151. Patient involvement in improving the evidence base on mental health inpatient care: the PERCEIVE programme
  152. Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study
  153. Controversies in Computerized Cognitive Training
  154. Why Reviewing Apps Is Not Enough: Transparency for Trust (T4T) Principles of Responsible Health App Marketplaces (Preprint)
  155. Liberal Acceptance Bias, Momentary Aberrant Salience, and Psychosis: An Experimental Experience Sampling Study
  156. The Emerging Imperative for a Consensus Approach Toward the Rating and Clinical Recommendation of Mental Health Apps
  157. Wearable technology in epilepsy: The views of patients, caregivers, and healthcare professionals
  158. Digital Exclusion Among Mental Health Service Users: Qualitative Investigation (Preprint)
  159. Barriers to and Facilitators of Engagement With Remote Measurement Technology for Managing Health: Systematic Review and Content Analysis of Findings
  160. Why is change a challenge in acute mental health wards? A cross‐sectional investigation of the relationships between burnout, occupational status and nurses’ perceptions of barriers to change
  161. Computerised working memory‐based cognitive remediation therapy does not affect Reading the Mind in The Eyes test performance or neural activity during a Facial Emotion Recognition test in psychosis
  162. Cognitive Remediation Therapy for Psychotic Major Depressive Disorder
  163. The COMMAND trial of cognitive therapy for harmful compliance with command hallucinations (CTCH): a qualitative study of acceptability and tolerability in the UK
  164. Using wearable technology to detect the autonomic signature of illness severity in schizophrenia
  165. The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial
  166. The COMMAND trial of cognitive therapy to prevent harmful compliance with command hallucinations: predictors of outcome and mediators of change
  167. The WPA- Lancet Psychiatry Commission on the Future of Psychiatry
  168. Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial
  169. Response to Letter 'Digital blind-spots: the role of symptom severity and user experience in digital intervention adherence' (Preprint)
  170. A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial
  171. Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory
  172. What is the impact of research champions on integrating research in mental health clinical practice? A quasiexperimental study in South London, UK
  173. Social cognition interventions for people with schizophrenia: a systematic review focussing on methodological quality and intervention modality
  174. Improving patient experiences of mental health inpatient care: a randomised controlled trial
  175. Improving Adherence to Web-Based and Mobile Technologies for People With Psychosis: Systematic Review of New Potential Predictors of Adherence
  176. Symptom fluctuations, self-esteem, and cohesion during group cognitive behaviour therapy for early psychosis
  177. National funding for mental health research in Finland, France, Spain and the United Kingdom
  178. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial
  179. Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients
  180. What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication
  181. Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis
  182. What proportion of patients with psychosis is willing to take part in research? A mental health electronic case register analysis
  183. Modeling the Interplay Between Psychological Processes and Adverse, Stressful Contexts and Experiences in Pathways to Psychosis: An Experience Sampling Study
  184. Improving Theory of Mind in Schizophrenia by Targeting Cognition and Metacognition with Computerized Cognitive Remediation: A Multiple Case Study
  185. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data
  186. Do We Still Have a Digital Divide in Mental Health? A Five-Year Survey Follow-up
  187. Using digital notifications to improve attendance in clinic: systematic review and meta-analysis
  188. A question of time: A study of time use in people with schizophrenia
  189. The optimisation of experience sampling protocols in people with schizophrenia
  190. The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia
  191. Cognitive–behaviour therapy for post-traumatic stress in schizophrenia. A randomized controlled trial
  192. Facilitating mental health research for patients, clinicians and researchers: a mixed-method study
  193. DEVELOPMENT AND VALIDATION OF ‘SURE’: A PATIENT REPORTED OUTCOME MEASURE (PROM) FOR RECOVERY FROM DRUG AND ALCOHOL DEPENDENCE
  194. The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial
  195. Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling study
  196. Group cognitive remediation therapy for chronic schizophrenia: A randomized controlled trial
  197. Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: Multicentre randomised controlled trial
  198. Following the Francis report: Investigating patient experience of mental health in-patient care
  199. ECLIPSE Study 9: Implementation of Remediation into EI Services
  200. Service user and carer priorities in a Biomedical Research Centre for mental health
  201. A Metacognitive Approach to Cognitive Remediation
  202. Psychosocial intervention in schizophrenia
  203. The feasibility and acceptability of a brief Acceptance and Commitment Therapy (ACT) group intervention for people with psychosis: The ‘ACT for life’ study
  204. Mental simulation and experience as determinants of performance expectancies in people with schizophrenia spectrum disorder
  205. Design in mind: eliciting service user and frontline staff perspectives on psychiatric ward design through participatory methods
  206. Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study
  207. Sense and readability: Participant information sheets for research studies
  208. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial
  209. Impact on the individual: what do patients and carers gain, lose and expect from being involved in research?
  210. Over promised, over-sold and underperforming? – e-health in mental health
  211. Substance Use Recovery Evaluator
  212. Defining continuity of care from the perspectives of mental health service users and professionals: an exploratory, comparative study
  213. Predicting psychiatric inpatient costs
  214. Emerging consensus on measuring addiction recovery: Findings from a multi-stakeholder consultation exercise
  215. Mental health research priorities for Europe
  216. Investigating the empirical support for therapeutic targets proposed by the temporal experience of pleasure model in schizophrenia: A systematic review
  217. Psychometric properties of a new treatment expectation scale in rheumatoid arthritis: an application of item response theory
  218. Predicting the future in schizophrenia: The discrepancy between anticipatory and consummatory pleasure
  219. Lessons learnt? The importance of metacognition and its implications for Cognitive Remediation in schizophrenia
  220. Electronic personal health records for people with severe mental illness; a feasibility study
  221. Cognitive remediation in schizophrenia—now it is really getting personal
  222. Modafinil combined with cognitive training: Pharmacological augmentation of cognitive training in schizophrenia
  223. Group cognitive remediation for schizophrenia: Exploring the role of therapist support and metacognition
  224. Tackling Social Cognition in Schizophrenia: A Randomized Feasibility Trial
  225. The Feasibility and Acceptability to Service Users of CIRCuiTS, a Computerized Cognitive Remediation Therapy Programme for Schizophrenia
  226. Cognitive Remediation in Schizophrenia
  227. Consenting for contact? Linking electronic health records to a research register within psychosis services, a mixed method study
  228. A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia
  229. Linking a research register to clinical records in older adults’ mental health services: a mixed-methods study
  230. A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia
  231. Cognition and social cognition in non-psychotic siblings of patients with schizophrenia
  232. The role of fear in mental health service users’ experiences: a qualitative exploration
  233. Potential mental health consequences for workers in the Ebola regions of West Africa – a lesson for all challenging environments
  234. Mobile early detection and connected intervention to coproduce better care in severe mental illness
  235. Top-Down Computerized Cognitive Remediation in Schizophrenia: A Case Study of an Individual with Impairment in Verbal Fluency
  236. Developing a new model for patient recruitment in mental health services: a cohort study using Electronic Health Records
  237. Staff and service users’ views on a ‘Consent for Contact’ research register within psychosis services: a qualitative study
  238. Collaborative development of an electronic Personal Health Record for people with severe and enduring mental health problems
  239. E.01.02 ROAMER – collaborative effort to develop a mental health research roadmap: the results
  240. The psychiatric ward as a therapeutic space: systematic review
  241. “You’re all going to hate the word ‘recovery’ by the end of this”: Service users’ views of measuring addiction recovery
  242. Understanding process in group cognitive behaviour therapy for psychosis
  243. Cognitive-behaviour therapy and schizophrenia
  244. The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study
  245. It is all in the factors: Effects of cognitive remediation on symptom dimensions
  246. Efficacy of a triage system to reduce length of hospital stay
  247. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial
  248. How should we measure addiction recovery? Analysis of service provider perspectives using online Delphi groups
  249. Poster #M98 OPTIMISING THE DELIVERY OF COGNITIVE REMEDIATION FOR SCHIZOPHRENIA – RESULTS FROM A FEASIBILITY RANDOMISED CONTROLLED TRIAL OF A NEW COMPUTERISED PROGRAMME, CIRCUITS
  250. Modafinil combined with cognitive training is associated with improved learning in healthy volunteers – A randomised controlled trial
  251. Does Change in Cognitive Function Predict Change in Costs of Care for People With a Schizophrenia Diagnosis Following Cognitive Remediation Therapy?
  252. Measuring community functioning in schizophrenia with the Social Behaviour Schedule
  253. The challenge of change in acute mental health services: measuring staff perceptions of barriers to change and their relationship to job status and satisfaction using a new measure (VOCALISE)
  254. Great expectations for participatory research: what have we achieved in the last ten years?
  255. Research Strategies and Priorities to Improve the Lives of People With Schizophrenia: Executive Summary of the Ernst Struungmann Forum on Schizophrenia
  256. Cognitive Therapies for Refractory Schizophrenia
  257. VOCALISE
  258. Stratified medicine for mental disorders
  259. ROAMER: roadmap for mental health research in Europe
  260. Life in acute mental health settings: experiences and perceptions of service users and nurses
  261. The h-index, the citation rating, impact factors and the aspiring researcher
  262. Identifying Cognitive Remediation Change Through Computational Modelling—Effects on Reinforcement Learning in Schizophrenia
  263. Inpatient care 50 years after the process of deinstitutionalisation
  264. Impact of patient involvement in mental health research: longitudinal study
  265. A trial of combining cognitive remediation and CBT for first episode psychosis
  266. Schizophrenia
  267. Schizophrenia
  268. Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process
  269. Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy
  270. Understanding processing speed—its subcomponents and their relationship to characteristics of people with schizophrenia
  271. Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediation
  272. Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem
  273. Specific vs general cognitive remediation for executive functioning in schizophrenia: A multicenter randomized trial
  274. Change in jumping to conclusions linked to change in delusions in early psychosis
  275. Can our politicians help to reduce stigma and discrimination?
  276. Expectations of new treatment in rheumatoid arthritis: developing a patient-generated questionnaire
  277. A Comparison of Two Delivery Modalities of a Mobile Phone-Based Assessment for Serious Mental Illness: Native Smartphone Application vs Text-Messaging Only Implementations
  278. Effects of Age and Cognitive Reserve on Cognitive Remediation Therapy Outcome in Patients With Schizophrenia
  279. Letter from the UK – Is this the end of mental health discrimination as we know it?
  280. Integrating mobile-phone based assessment for psychosis into people’s everyday lives and clinical care: a qualitative study
  281. Increased funding needed for mental health research
  282. Patient involvement in improving the evidence base on inpatient care: improving inpatient therapeutic environments
  283. The effectiveness of cognitive remediation therapy (CRT) for patients with schizophrenia
  284. Cognitive remediation for young people with schizophrenia
  285. Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication
  286. Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia – a multi-centre randomised controlled trial
  287. Patient involvement - inpatient care (WP3)
  288. Computerised Cognitive Remediation Therapy for Schizophrenia
  289. Patient involvement in improving the evidence base on inpatient care: changing service configuration - the "triage" model
  290. A systematic review of cognitive remediation for schizo-affective and affective disorders
  291. Assessing your mood online: acceptability and use of Moodscope
  292. Views of the Therapeutic Environment (VOTE): Stakeholder involvement in measuring staff perceptions of acute in-patient care
  293. The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application
  294. S.09.01 The role of contextual factors in predicting cognitive improvement
  295. Hearing the voices of service user researchers in collaborative qualitative data analysis: the case for multiple coding
  296. Holding blame at bay? ‘Gene talk’ in family members’ accounts of schizophrenia aetiology
  297. Continuity of care for carers of people with severe mental illness: Results of a longitudinal study
  298. E-mental health – a land of unlimited possibilities
  299. Cognitive remediation therapy for young people with schizophrenia
  300. The Effect of Working Alliance on Adherence and Outcome in Cognitive Remediation Therapy
  301. Can't surf, won't surf: The digital divide in mental health
  302. Developing a tool for collecting and costing activity data on psychiatric inpatient wards
  303. A case series exploring possible predictors and mechanisms of change in hearing voices groups
  304. Understanding service user-defined continuity of care and its relationship to health and social measures: a cross-sectional study
  305. An exploratory investigation of real‐world reasoning in paranoia
  306. Developing models of how cognitive improvements change functioning: Mediation, moderation and moderated mediation
  307. Depression and anxiety in schizophrenia
  308. Family interventions in schizophrenia
  309. Cognitive dysfunction in schizophrenia
  310. Developing support for mental health clinical research: the Mental Health Research Network experience
  311. PSYCHOSOCIAL AND COMORBIDITIES
  312. Poster #148 COGNITIVE RESERVE: DOES IT MODIFY THE EFFECT OF AGE ON COGNITIVE REMEDIATION THERAPY OUTCOME IN SCHIZOPHRENIA?
  313. Group CBT for Early Psychosis—Are There Still Benefits One Year Later?
  314. Effects of Age and Cognitive Reserve on Cognitive Remediation Therapy Outcome in Patients With Schizophrenia
  315. VOICE: Developing a new measure of service users' perceptions of inpatient care, using a participatory methodology
  316. AS02-01 - Improving cognition and function - style trumps content
  317. Views of the Therapeutic Environment Measure
  318. CITRINE Tool
  319. Cognitive Behaviour Therapy for Psychosis: The Impact of Therapist Training and Supervision
  320. Extending the clinical research network approach to all of healthcare
  321. Does Change in Cannabis Use in Established Psychosis Affect Clinical Outcome?
  322. A multi-centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations
  323. Continuity of care for people with psychotic illness: Its relationship to clinical and social functioning
  324. Psychiatric patients’ views on why their involuntary hospitalisation was right or wrong: a qualitative study
  325. Thinking About the Future Cognitive Remediation Therapy--What Works and Could We Do Better?
  326. Rapid progress or lengthy process? electronic personal health records in mental health
  327. Selecting outcome measures in mental health: the views of service users
  328. Erratum to “No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia” [Neurosci. Lett. 496 (2011) 65–69]
  329. A review of hearing voices groups: Evidence and mechanisms of change
  330. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: Developing Imaging Biomarkers to Enhance Treatment Development for Schizophrenia and Related Disorders
  331. No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia
  332. Close to the bench as well as at the bedside: involving service users in all phases of translational research
  333. A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
  334. Tower of London versus Real Life Analogue Planning in Schizophrenia with Disorganization and Psychomotor Poverty Symptoms
  335. The Madrid Declaration: why we need a coordinated Europe-wide effort in mental health research
  336. Achieving Continuity of Care: Facilitators and Barriers in Community Mental Health Teams
  337. A Comparison of Participant Information Elicited by Service User and Non-Service User Researchers
  338. A model for developing outcome measures from the perspectives of mental health service users
  339. Revisiting Cognitive Remediation for Schizophrenia: Facing the Challenges of the Future
  340. Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study
  341. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial
  342. Cognitive remediation therapy needs funding
  343. Review: cognitive impairment present in people with affective psychoses
  344. Can we harness computerised cognitive bias modification to treat anxiety in schizophrenia? A first step highlighting the role of mental imagery
  345. Needs of homeless people for mental healthcare
  346. Review: cognitive impairment present in people with affective psychoses
  347. Diagnosis, diagnosis, diagnosis: towards DSM-5
  348. Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis
  349. Nurse and patient activities and interaction on psychiatric inpatients wards: A literature review
  350. Group Cognitive Behaviour Therapy for psychosis
  351. HOW EFFECTIVE IS CBTP AND DOES THIS DEPEND ON YOUR THERAPIST?
  352. IMPROVING OVERALL OUTCOMES - EXTENDING CBTP TO COMPLEX PROBLEMS
  353. WHAT FACTORS PREDICT AWARENESS OF COGNITIVE PROBLEMS IN PEOPLE WITH SCHIZOPHRENIA?
  354. Coercion and Treatment Satisfaction Among Involuntary Patients
  355. Imagery and Task-Feedback Questionnaire
  356. Ethnicity and coercion among involuntarily detained psychiatric in-patients
  357. Impaired verbal self-monitoring in individuals at high risk of psychosis
  358. Different Components of Metacognition and their Relationship to Psychotic-Like Experiences
  359. Evaluating integrated MI and CBT for people with psychosis and substance misuse: Recruitment, retention and sample characteristics of the MIDAS trial
  360. Promoting Therapeutic Alliance in Clozapine Users: An Exploratory Randomized Controlled Trial
  361. Does age matter? Effects of cognitive rehabilitation across the age span
  362. Illness careers and continuity of care in mental health services: A qualitative study of service users and carers
  363. The self or the voice? Relative contributions of self-esteem and voice appraisal in persistent auditory hallucinations
  364. Developing a user-generated measure of continuity of care: brief report
  365. Cognitive remediation for schizophrenia: it is even more complicated
  366. Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS Meeting
  367. Patients' views and readmissions 1 year after involuntary hospitalisation
  368. Group Cognitive Behavior Therapy or Social Skills Training for Individuals With a Recent Onset of Psychosis?
  369. Review: Cognitive remediation improves cognitive functioning in schizophrenia
  370. Executive functioning in schizophrenia and the relationship with symptom profile and chronicity
  371. Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative
  372. Letter to the Editor: Neuropsychological task performance before and after cognitive remediation in anorexia nervosa: a pilot case-series
  373. Continuity of care in mental health: understanding and measuring a complex phenomenon
  374. COGNITION REHABILITATION IN SCHIZOPHRENIA, II: COGNITION REHABILITATION, COSTS AND EFFECTIVENESS
  375. A PILOT STUDY OF A NEW COMPUTERISED COGNITIVE REMEDIATION PROGRAMME
  376. What Do Clients Think of Cognitive Remediation Therapy?: A Consumer-Led Investigation of Satisfaction and Side Effects
  377. Cognitive remediation and vocational rehabilitation.
  378. Mental health and perceptions of biomarker research – possible effects on participation
  379. What are mental health service users' priorities for research in the UK?
  380. Measurement Issues in the Use of Cognitive Neuroscience Tasks in Drug Development for Impaired Cognition in Schizophrenia: A Report of the Second Consensus Building Conference of the CNTRICS Initiative
  381. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: An exploratory randomized controlled trial
  382. Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor
  383. Cognitive remediation therapy in schizophrenia
  384. Til Wykes
  385. Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop
  386. More than just a place to talk: Young people's experiences of group psychological therapy as an early intervention for auditory hallucinations
  387. WC12C GROUP CBT VS SKILLS TRAINING FOR FIRST EPISODES OF PSYCHOSIS – RESULTS OF A RCT
  388. Cognitive Predictors of Social Functioning Improvements Following Cognitive Remediation for Schizophrenia
  389. Cognitive Remediation Therapy for Schizophrenia
  390. Group Treatment of Perceived Stigma and Self-Esteem in Schizophrenia: A Waiting List Trial of Efficacy
  391. Schizophrenia Patients With Cognitive Deficits: Factors Associated With Costs
  392. Negative Symptoms and Specific Cognitive Impairments as Combined Targets for Improved Functional Outcome Within Cognitive Remediation Therapy
  393. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial
  394. Early Psychological Intervention for Auditory Hallucinations: An Exploratory Study of Young People??s Voices Groups
  395. Information, consent and perceived coercion: patients' perspectives on electroconvulsive therapy
  396. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?
  397. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: Cluster randomised controlled trial
  398. There's more than one way to have an impact
  399. Consumers' views of electroconvulsive therapy: A qualitative analysis
  400. Reshaping mental health practice with evidence: the Mental Health Research Network
  401. Psychological treatment for voices in psychosis
  402. What kind of mental health research should we be doing in the 21st century?—Mental Health Research Networks
  403. Modification of performance on the Span of Apprehension Task in a group of young people with early onset psychosis
  404. School performance in secondary education shows no decline before the onset of a first episode of psychosis in schizophrenia
  405. Continuation of clozapine treatment: practice makes perfect
  406. Anger, psychopathology and cognitive inhibition: a study of UK servicemen
  407. Group CBT for Clients With a First Episode of Schizophrenia
  408. Patients' perspectives on electroconvulsive therapy: systematic review
  409. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia
  410. Which cognitive skills should we target in cognitive remediation therapy?
  411. The effect of medication management training on community mental health nurse's clinical skills
  412. Effects of Depressed Mood on Objective and Subjective Measures of Attention
  413. 'People don't understand': An investigation of stigma in schizophrenia using Interpretative Phenomenological Analysis (IPA)
  414. Blue skies in the Journal of Mental Health? Consumers in research
  415. Educating acute inpatients about their medication: Is it worth it? An exploratory study of group education for patients on a psychiatric intensive care unit
  416. Stigma, discrimination and mental illness
  417. From passive subjects to equal partners
  418. Are all psychological treatments for psychosis equal? The need for CBT in the treatment of psychosis and not for psychodynamic psychotherapy
  419. Cognitive functioning and disturbances of mood in UK veterans of the Persian Gulf War: a comparative study
  420. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication
  421. 'Next steps' on JMH - reform and consolidation
  422. What are the research priorities of mental health service users?
  423. IS IT TIME TO DEVELOP A NEW COGNITIVE THERAPY FOR PSYCHOSIS—COGNITIVE REMEDIATION THERAPY (CRT)?
  424. The use of outcome measures to evaluate the efficacy and tolerability of antipsychotic medication: a comparison of Thorn graduate and CPN practice
  425. The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia
  426. Cerebral lateralization of global–local processing in people with schizotypy
  427. The Rehabilitation of Cognitive Deficits
  428. Cognitive impairment in early onset schizophrenia: associations with clinical symptoms
  429. Community rehabilitation: past failures and future prospects
  430. Group treatment of auditory hallucinations
  431. The Effects of Neurocognitive Remediation on Executive Processing in Patients With Schizophrenia
  432. What are we changing with neurocognitive rehabilitation?
  433. The Homeless Clients of a Community Psychiatric Nursing Service in Inner London: 1. Demographic Characteristics and Presenting Problems
  434. The Homeless Clients of a Community Psychiatric Nursing Service in Inner London: 2. Referral Process and Main Intervention
  435. A randomised control trial of individual neurocognitive remediation: The effects on cognitive deficits & general functioning
  436. Aversive stimulation by staff and violence by psychiatric patients
  437. Response inhibition: A stable vulnerability factor in chronic schizophrenia
  438. Global Function Scales
  439. Psychosocial factors in schizophrenia
  440. Predicting symptomatic and behavioural outcomes of community care
  441. Introduction
  442. Reactions to assault
  443. Violence and Health Care Professionals
  444. Counselling for victims of violence
  445. The prediction of violence in a health care setting
  446. Developments in clinical psychology
  447. Global function scales
  448. Patient satisfaction with intensive care psychiatric services: Can it be assessed?
  449. The assessment of severely disabled psychiatric patients for rehabilitation
  450. Attitudes of relatives of Afro-Caribbean patients: do they affect admission?
  451. Violence and suicidality: Perspectives in clinical and psychobiological research
  452. The relation between life events and social support networks in a clinically depressed cohort
  453. Clinical treatment of the violent person
  454. Assessment schedules for chronic psychiatric patients
  455. The Interview Measure of Social Relationships: The description and evaluation of a survey instrument for assessing personal social resources
  456. The psychological difference between temporally predictable and unpredictable stressful events: Evidence for information control theories.
  457. The assessment of patients' needs for community care
  458. A follow-up of ‘new’ long-stay patients in Camberwell, 1977–1982
  459. The role of inferences in children's comprehension of pronouns
  460. Disordered speech: Differences between manics and schizophrenics
  461. 4. Needs and the deployment of services
  462. 3. The role of relatives
  463. Inference and children's comprehension of pronouns
  464. Language and schizophrenia
  465. How do children learn the meanings of verbs?
  466. Cognitive Behaviour Therapy
  467. The toxicity of community care
  468. Cognitive Behaviour Therapy
  469. Antidepressant Medications in Clinical Practice